Hydroxyurea Cytodrox Capsules

Name: Hydroxyurea Cytodrox Capsules
Brand: Welox Pharma Private Limited
Price: 750 INR
Availability: InStock

Price 750 INR/ Box

Get a Price/Quote

MOQ : 100 Boxes

Hydroxyurea Cytodrox Capsules Specification

Packaging Type
Box

Pacakaging (Quantity Per Box)
10 Capsules

Indication
Safe persistent myelocytic leukemia

Salt Composition
Cytodrox 500mg Capsule

Brand Name
Cytodrox

Drug Type
Prescription

Physical Form
Capsule

Quantity
10 capsules/box

Manufactured By
Cipla

Strength
500 mg

Hydroxyurea Cytodrox Capsules Trade Information

Minimum Order Quantity
100 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Boxes Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Hydroxyurea Cytodrox Capsules

Cipla's Cytodrox Hydroxyurea 500 mg Capsules, also known as Cytodrox, are a peerless solution in treating chronic myelocytic leukemia. Offered at the best price for their grade, these prescription capsules have garnered favorable reviews from both patients and healthcare professionals. Each box houses 10 rare and potent capsules, underlining Cipla's ace pharmaceutical excellence. Formulated with precision and safety in mind, Cytodrox stands out as a sublime choice for those seeking trusted and effective treatment options from a reputable manufacturer, supplier, and trader in India.

Targeted Application and Usage

Hydroxyurea Cytodrox Capsules are specifically crafted for oral administration, mostly applied in clinical settings for managing safe persistent myelocytic leukemia. The general use involves following a doctor's prescription, while the specific use is for long-term treatment in patients diagnosed with the mentioned condition. The capsule form ensures dosage accuracy and ease of use, making it suitable for adults requiring cytoreductive therapy.

Shipping, Export, and Domestic Market Presence

Cipla's Cytodrox Hydroxyurea is shipped via main FOB ports across India, suitable for both export and domestic proposals. Arrival timelines are managed efficiently to ensure timely fulfillment. The product caters to main export markets, including Asia, Africa, and the Middle East, besides a strong domestic market presence. Outlay considerations are competitive, ensuring that buyers obtain ace therapeutic value in proportion to proposal amounts for each consignment.

FAQ's of Hydroxyurea Cytodrox Capsules:

Q: How should Hydroxyurea Cytodrox Capsules be taken for optimal results?

A: Hydroxyurea Cytodrox Capsules should be taken exactly as prescribed by your healthcare provider, typically by mouth with water. Follow the recommended dosage and duration to maximize therapeutic outcomes and minimize potential side effects.

Q: What conditions are specifically treated with Cytodrox 500mg Capsules?

A: Cytodrox 500mg Capsules are primarily indicated for the treatment of persistent myelocytic leukemia. They may also be used in other clinical scenarios as deemed appropriate by medical professionals.

Q: When can patients expect to see benefits from using Cytodrox?

A: The benefits of Cytodrox may begin to appear within a few weeks of consistent use, although the timeframe can vary depending on individual patient response and the exact nature of the condition being treated.

Q: Where is Cytodrox manufactured and how is it supplied?

A: Cytodrox is manufactured by Cipla in India and supplied in boxes containing 10 capsules each. These are available to both domestic and international markets.

Q: What is the process for procuring Hydroxyurea Cytodrox Capsules for export?

A: Buyers can initiate a proposal amount for orders via Cipla's appointed distributors. Upon confirmation, shipment is arranged through main FOB ports, ensuring transparent arrival and efficient handling.

Q: How is Hydroxyurea Cytodrox beneficial for patients with chronic myelocytic leukemia?

A: Cytodrox helps to manage and reduce the proliferation of leukemia cells, thereby slowing disease progression and improving patient prognosis as prescribed by a healthcare specialist.